We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BTRW:LSEBarratt Redrow plc Analysis

Data as of 2026-03-11 - not real-time

£299.90

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Barratt Redrow is trading near a key support level with a bearish technical backdrop – the RSI is deep in oversold territory, the MACD histogram is negative and the 20‑day SMA sits well below the current price, signaling continued downside pressure. Volatility is elevated while the beta reading suggests limited correlation to broader market moves, and the DCF fair‑value estimate is dramatically lower than the market price, indicating the stock is overvalued. The dividend yield appears attractive but the payout ratio exceeds 100%, raising questions about sustainability.
Fundamentally, the company posted solid revenue growth and higher home completions, yet margins are thin and free cash flow remains negative, with debt levels high relative to equity. Recent analyst commentary highlights margin compression despite volume gains, a trimmed profit forecast from Deutsche Bank, and a reduced price target from RBC, though the consensus rating remains a buy. The mix of strong top‑line momentum, stressed profitability, and an inflated valuation suggests caution in the near term, while the long‑run housing demand could restore upside if the price corrects.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Bearish technical indicators (RSI, MACD, price near support)
  • Margin compression and recent profit forecast downgrade
  • Elevated volatility with limited upside potential

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Continued revenue growth and strong home completion rates
  • High dividend yield offset by unsustainable payout ratio
  • Overvaluation relative to DCF fair value

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑term UK housing demand and land bank potential
  • Opportunity for price correction toward intrinsic value
  • Potential improvement in cash flow and dividend sustainability

Key Metrics & Analysis

Financial Health

Revenue Growth15.40%
Profit Margin3.64%
P/E Ratio20.0
ROE2.76%
ROA3.03%
Debt/Equity3.24
P/B Ratio54.7
Op. Cash Flow£112.4M
Free Cash Flow£-77225000

Technical Analysis

TrendBearish
RSI17.0
Support£299.20
Resistance£400.00
MA 20£354.82
MA 50£372.11
MA 200£388.11
MACDBearish
VolumeIncreasing
Fear & Greed Index76.39

Valuation

Fair Value£156.01
Target Price£471.11
Upside/Downside57.09%
GradeOvervalued
TypeValue
Dividend Yield5.64%

Risk Assessment

Beta0.28
Volatility30.40%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.